NASDAQUtilitiesRegulated WaterSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Improve cash flow from operations to positive territory | A supporting condition in Pure Cycle Corp.'s published investment case. The stated target is Cash from operations > $0 by FY 2026 end. | Improving | Cash flow remains negative through FY 2026 | Cash from operations: $3.469M FY2026-Q3; GAAP. Published target: Cash from operations > $0 by FY 2026 end. Target period is not explicitly aligned with this observation. Source published Jul 8, 20263,469,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q3 · Period ending May 31, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q3. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextManagement stated this priority in 3 of last 3 quarters. Cash and cash equivalents increased from $4.8 million in 2026-Q2 to $8.4 million in 2026-Q3, despite negative operating cash flow of -$4.2 million in Q2 due to investments in development and infrastructure. The company is managing liquidity to support growth and shareholder returns, showing mixed progress on cash flow enhancement. Delivery assessment Oct 24, 2026 |
Achieve EPS guidance range of $0.24 to $0.51 in FY 2026 | Pure Cycle aims to meet its EPS guidance of $0.24 to $0.51 for fiscal 2026. | Broken | EPS falls below $0.24 for FY 2026 | Diluted EPS: $0.12 per share FY2026-Q3; GAAP. Published target: EPS between $0.24 and $0.51 for FY 2026. Target period is not explicitly aligned with this observation. Source published Jul 8, 20260.12 USD/share · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q3 · Period ending May 31, 2026 Source: company_financial_results. Reference: 1a845fee-c08b-4d24-820c-5ab092dca1b6. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 3 of last 3 quarters. Diluted EPS increased from $0.05 in 2026-Q1 to $0.12 in 2026-Q3, with net income growing 31% year-over-year in Q3 2026. Management reports having achieved approximately 71% of full-year net income and EPS guidance by Q3 2026, indicating the company is delivering on this priority. Delivery assessment Oct 24, 2026 |
Maintain revenue growth to meet or exceed FY 2026 guidance of at least $20.024B | Pure Cycle aims to meet its EPS guidance of $0.24 to $0.51 for fiscal 2026. | Intact | Revenue falls below $20 billion in FY 2026 | Revenue: $8.222M FY2026-Q3; GAAP. Published target: Revenue >= $20.024 billion for FY 2026. Target period is not explicitly aligned with this observation. Source published Jul 8, 20268,222,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q3 · Period ending May 31, 2026 Source: company_financial_results. Reference: 1a845fee-c08b-4d24-820c-5ab092dca1b6. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextManagement emphasized this priority in 3 of last 3 quarters. Revenue increased from $5.1 million in 2025-Q3 to $8.2 million in 2026-Q3 (+60%), and nine-month revenue grew 51% year-over-year. The trajectory is delivering consistent revenue growth across segments. Delivery assessment Oct 24, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 11, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a small-cap utility growth story, not yet a durable compounder, with a multi-year view that depends on continued growth and delivery against guidance. The thesis state is watch, although the signal recently shifted from mixed to mildly favorable.
The valuation evidence is mixed: one measure says PCYO is cheap versus peers, while another puts its premium to peers at 0.88 and the overall value assessment is expensive. The priced-in tag is justified, with no measured expectations gap, so the snapshot does not show a clear mismatch between expectations and execution.
Near term, results are weak relative to the industry cohort, and the company has missed across recent quarters, though the latest performance has not freshly broken the thesis. Through Q3 2026, revenue rose 60% year over year and diluted EPS increased, while management reported reaching about 71% of full-year net income and EPS guidance. Cash flow progress is mixed, and a guidance cut on the next call remains a meaningful risk.
The multi-year thesis hinges on management completing FY 2026 guidance and sustaining revenue growth while improving cash generation. A guidance cut would weaken the case, while lower interest rates or continued strong results from utility peers could provide a sector tailwind. These scenarios matter, but the evidence here is thin on how much they would change PCYO’s own operating outlook.
Over the next 1 to 3 years, PCYO has signs of operating progress but still faces weak relative performance, elevated risk, and an expensive overall value assessment. The thesis depends on guidance delivery and stronger cash generation. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.